The authors observed increased expression of IL-10 and IL-13 and decreased expression of IL-1β, IL-6, interferon gamma (IFN-γ), TNF-α, IL-12, and IGF-1 in peripheral blood mononuclear cells (PBMCs) derived from patients with colorectal cancer. This evidence concerns the gene IL10 and colorectal cancer.